Optimization of Timing and Times for Administration of Atorvastatin‐Pretreated Mesenchymal Stem Cells in a Preclinical Model of Acute Myocardial Infarction

Abstract Our previous studies showed that the combination of atorvastatin (ATV) and single injection of ATV‐pretreated mesenchymal stem cells (MSCs) (ATV‐MSCs) at 1 week post‐acute myocardial infarction (AMI) promoted MSC recruitment and survival. This study aimed to investigate whether the combinat...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jun Xu, Yu‐Yan Xiong, Qing Li, Meng‐Jin Hu, Pei‐Sen Huang, Jun‐Yan Xu, Xia‐Qiu Tian, Chen Jin, Jian‐Dong Liu, Li Qian, Yue‐Jin Yang
Formato: article
Lenguaje:EN
Publicado: Wiley 2019
Materias:
Acceso en línea:https://doaj.org/article/57d7d78e30a040a482f09c50611cba82
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!